(Q33723491)

28 July 2017

title

Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, China (English)

1 reference

28 July 2017

Yuanxi Jia

1

1 reference

28 July 2017

Li Li

2

1 reference

28 July 2017

Fuqiang Cui

3

1 reference

28 July 2017

Dongliang Zhang

4

1 reference

28 July 2017

Guomin Zhang

5

1 reference

28 July 2017

Fuzhen Wang

6

1 reference

28 July 2017

Xiaohong Gong

7

1 reference

28 July 2017

Hui Zheng

8

1 reference

28 July 2017

Zhenhua Wu

9

1 reference

28 July 2017

Ning Miao

10

1 reference

28 July 2017

Xiaojin Sun

11

1 reference

28 July 2017

Li Zhang

12

1 reference

28 July 2017

Jingjing Lv

13

1 reference

28 July 2017

Feng Yang

14

1 reference

28 July 2017

publication date

1 January 2014

1 reference

Human Vaccines & Immunotherapeutics

28 July 2017

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

issue

10

1 reference

28 July 2017

page(s)

2983-2991

1 reference

Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

A thirty-one year prospective follow-up program on the HBsAg carrier state and primary liver cancer in Qidong, China

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Assessment of total economic burden of chronic hepatitis B (CHB)-related diseases in Beijing and Guangzhou, China

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Health-state utilities in liver disease: a systematic review.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

[A retrospective cohort study on the natural history of chronic hepatitis Beta in Shanghai, China].

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

The estimation of a preference-based measure of health from the SF-36.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Long term follow-up studies of patients surviving fluminant viral hepatitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.29944

Economic evaluation of universal newborn hepatitis B vaccination in China

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Natural history of liver cirrhosis in south China based on a large cohort study in one center: a follow-up study for up to 5 years in 920 patients.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

[Financial burden of hepatitis B-related diseases and factors influencing the costs in Shenzhen, China].

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Evaluation on impact of hepatitis B vaccine integrated into routine immunization in the areas of Ministry of Health/Global Alliance for Vaccine and Immunization (GAVI) Cooperation Project P.R. China

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

The Cost Effectiveness of Hepatitis Immunization for US College Students

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

Estimating an EQ-5D population value set: the case of Japan.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5443099

The influence of age on the development of the hepatitis B carrier state

30 October 2018

1 reference

12 December 2020

Comparing Cost-Utility Estimates

1 reference

12 December 2020

Hepatitis B vaccines: WHO position paper--recommendations

1 reference

12 December 2020

[Study on the natural history of chronic hepatitis B]

1 reference

12 December 2020

[A follow-up study on 103 HBsAg carriers during 16-21 years]

1 reference

12 December 2020

[Study on the cost-effectiveness, benefit and utility analysis on the infant inoculation hepatitis B vaccine in Shanghai]

1 reference

12 December 2020

[Cost-effectiveness analysis of hepatitis B vaccination in People's Liberation Army]

1 reference

12 December 2020

Identifiers

DOI

10.4161/HV.29944

1 reference

28 July 2017

1 reference

28 July 2017

1 reference